Literature DB >> 19095140

Additional lipid lowering trials using surrogate measurements of atherosclerosis by carotid intima-media thickness: more clarity or confusion?

Evan A Stein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19095140     DOI： 10.1016/j.jacc.2008.11.002

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  5 in total

1.  Low-density lipoprotein cholesterol reduction and prevention of cardiovascular disease.

Authors:  Evan A Stein
Journal:  Mayo Clin Proc       Date:  2009-04       Impact factor: 7.616

2.  Lipid lowering and imaging protease activation in atherosclerosis.

Authors:  Mahmoud Razavian; Lei Nie; Azariyas Challa; Jiasheng Zhang; Reza Golestani; Jae-Joon Jung; Simon Robinson; Mehran M Sadeghi
Journal:  J Nucl Cardiol       Date:  2013-12-25       Impact factor: 5.952

3.  Effect of ezetimibe on major atherosclerotic disease events and all-cause mortality.

Authors:  Sami Hayek; Fabrizio Canepa Escaro; Assad Sattar; Steven Gamalski; Karen E Wells; George Divine; Brian K Ahmedani; David E Lanfear; Manel Pladevall; L Keoki Williams
Journal:  Am J Cardiol       Date:  2012-12-04       Impact factor: 2.778

4.  Relative growth hormone deficiency and cortisol excess are associated with increased cardiovascular risk markers in obese adolescent girls.

Authors:  M Russell; M Bredella; P Tsai; N Mendes; K K Miller; A Klibanski; M Misra
Journal:  J Clin Endocrinol Metab       Date:  2009-05-12       Impact factor: 5.958

Review 5.  Ezetimibe therapy: mechanism of action and clinical update.

Authors:  Binh An P Phan; Thomas D Dayspring; Peter P Toth
Journal:  Vasc Health Risk Manag       Date:  2012-07-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.